In silico mechanistic models for glycosylation are investigated for biotherapeutics development and production. The models systematically describe the transport-kinetics of glycosylation process and serve as a prediction framework for glycan profile. However, inputs for those models are generally limited to intracellular parameters, such as enzymatic activity and nucleotide sugar concentration. These intracellular metabolites are unfortunately inaccessible in process. To modulate those models for glycoform prediction in culture process, linkage between measurable culture variations and the intracellular metabolites change will be thoroughly investigated. The measurable metabolites and intracellular variables associated with in silico glycos...
The glycosylation profiles of biopharmaceuticals have a major impact on the bioactivity, bioavailabi...
The glycosylation pathway is a highly branched network. Although only a relatively small number of e...
All commercially-available therapeutic monoclonal antibodies (mAbs) contain a consensus N-linked gly...
In silico mechanistic models for glycosylation are investigated for biotherapeutics development and ...
Glycoproteins represent the largest group of the growing number of biologically-derived medicines. T...
Glycoproteins represent the largest group of the growing number of biologically-derived medicines. T...
N-linked glycosylation is known to be a crucial factor for the therapeutic efficacy and safety of mo...
Glycoproteins make up the bulk of biologically-derived medicines, and are taking up an ever increasi...
Protein glycosylation is one of the most important product quality attributes and impacts efficacy, ...
The Chinese hamster ovary (CHO) cell is the gold standard for manufacturing of glycosylated recombin...
Lee, Kelvin H.Advancements in biopharmaceutical research, development, and manufacturing have led t...
N-linked glycosylation affects the potency, safety, immunogenicity, and pharmacokinetic clearance of...
The production of recombinant therapeutic monoclonal antibodies (mAbs) using cultured mammalian cell...
<div><p>The Chinese hamster ovary (CHO) cell is the gold standard for manufacturing of glycosylated ...
Abstract Background The glycosylation of recombinant proteins can be altered by a range of parameter...
The glycosylation profiles of biopharmaceuticals have a major impact on the bioactivity, bioavailabi...
The glycosylation pathway is a highly branched network. Although only a relatively small number of e...
All commercially-available therapeutic monoclonal antibodies (mAbs) contain a consensus N-linked gly...
In silico mechanistic models for glycosylation are investigated for biotherapeutics development and ...
Glycoproteins represent the largest group of the growing number of biologically-derived medicines. T...
Glycoproteins represent the largest group of the growing number of biologically-derived medicines. T...
N-linked glycosylation is known to be a crucial factor for the therapeutic efficacy and safety of mo...
Glycoproteins make up the bulk of biologically-derived medicines, and are taking up an ever increasi...
Protein glycosylation is one of the most important product quality attributes and impacts efficacy, ...
The Chinese hamster ovary (CHO) cell is the gold standard for manufacturing of glycosylated recombin...
Lee, Kelvin H.Advancements in biopharmaceutical research, development, and manufacturing have led t...
N-linked glycosylation affects the potency, safety, immunogenicity, and pharmacokinetic clearance of...
The production of recombinant therapeutic monoclonal antibodies (mAbs) using cultured mammalian cell...
<div><p>The Chinese hamster ovary (CHO) cell is the gold standard for manufacturing of glycosylated ...
Abstract Background The glycosylation of recombinant proteins can be altered by a range of parameter...
The glycosylation profiles of biopharmaceuticals have a major impact on the bioactivity, bioavailabi...
The glycosylation pathway is a highly branched network. Although only a relatively small number of e...
All commercially-available therapeutic monoclonal antibodies (mAbs) contain a consensus N-linked gly...